Literature DB >> 19580262

The medicinal applications of imidazolium carbene-metal complexes.

Khadijah M Hindi1, Matthew J Panzner, Claire A Tessier, Carolyn L Cannon, Wiley J Youngs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19580262      PMCID： PMC2763352          DOI： 10.1021/cr800500u

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  103 in total

1.  Stable Carbenes.

Authors:  Didier Bourissou; Olivier Guerret; François P. Gabbaï; Guy Bertrand
Journal:  Chem Rev       Date:  2000-01-12       Impact factor: 60.622

2.  Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II).

Authors:  B Cetinkaya; E Cetinkaya; H Küçükbay; R Durmaz
Journal:  Arzneimittelforschung       Date:  1996-08

3.  Inhibition of cancer cell growth by ruthenium(II) arene complexes.

Authors:  R E Morris; R E Aird; P del S Murdoch; H Chen; J Cummings; N D Hughes; S Parsons; A Parkin; G Boyd; D I Jodrell; P J Sadler
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

4.  Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium(II) complex trans-bis[endo-(1R)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-amino]palladium(II)dichloride.

Authors:  Adnan S Abu-Surrah; Talal A K Al-Allaf; Luay J Rashan; Martti Klinga; Markku Leskelä
Journal:  Eur J Med Chem       Date:  2002-11       Impact factor: 6.514

5.  Formation of water-soluble pincer silver(I)-carbene complexes: a novel antimicrobial agent.

Authors:  Abdulkareem Melaiye; Richard S Simons; Amy Milsted; Francesco Pingitore; Chrys Wesdemiotis; Claire A Tessier; Wiley J Youngs
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

6.  Silver. 2: Toxicity in mammals and how its products aid wound repair.

Authors:  A B G Lansdown
Journal:  J Wound Care       Date:  2002-05       Impact factor: 2.072

7.  Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate.

Authors:  B W East; K Boddy; E D Williams; D Macintyre; A L Mclay
Journal:  Clin Exp Dermatol       Date:  1980-09       Impact factor: 3.470

8.  The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture.

Authors:  J Liu; W C Kershaw; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1991-01       Impact factor: 4.219

9.  Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.

Authors:  C K Mirabelli; R K Johnson; C M Sung; L Faucette; K Muirhead; S T Crooke
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

10.  Effects of hypoxia and transferrin on toxicity and DNA binding of ruthenium antitumor agents in hela cells.

Authors:  D Frasca; J Ciampa; J Emerson; R S Umans; M J Clarke
Journal:  Met Based Drugs       Date:  1996
View more
  46 in total

1.  Synthesis of 4- and 4,5-functionalized imidazol-2-ylidenes from a single 4,5-unsubstituted imidazol-2-ylidene.

Authors:  Daniel Mendoza-Espinosa; Bruno Donnadieu; Guy Bertrand
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

2.  A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens.

Authors:  Matthew J Panzner; Khadijah M Hindi; Brian D Wright; Jane B Taylor; Daniel S Han; Wiley J Youngs; Carolyn L Cannon
Journal:  Dalton Trans       Date:  2009-08-06       Impact factor: 4.390

3.  Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide).

Authors:  Young H Lim; Kristin M Tiemann; Gyu Seong Heo; Patrick O Wagers; Yohannes H Rezenom; Shiyi Zhang; Fuwu Zhang; Wiley J Youngs; David A Hunstad; Karen L Wooley
Journal:  ACS Nano       Date:  2015-01-26       Impact factor: 15.881

4.  Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.

Authors:  Cátia Ornelas-Megiatto; Parth N Shah; Peter R Wich; Jessica L Cohen; Jasur A Tagaev; Justin A Smolen; Brian D Wright; Matthew J Panzner; Wiley J Youngs; Jean M J Fréchet; Carolyn L Cannon
Journal:  Mol Pharm       Date:  2012-10-19       Impact factor: 4.939

5.  Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics.

Authors:  Yali Li; Khadijah Hindi; Kristin M Watts; Jane B Taylor; Ke Zhang; Zicheng Li; David A Hunstad; Carolyn L Cannon; Wiley J Youngs; Karen L Wooley
Journal:  Chem Commun (Camb)       Date:  2009-11-09       Impact factor: 6.222

6.  Silver metallation of hen egg white lysozyme: X-ray crystal structure and NMR studies.

Authors:  Matthew J Panzner; Stephanie M Bilinovich; Wiley J Youngs; Thomas C Leeper
Journal:  Chem Commun (Camb)       Date:  2011-10-31       Impact factor: 6.222

Review 7.  Stable cyclic carbenes and related species beyond diaminocarbenes.

Authors:  Mohand Melaimi; Michèle Soleilhavoup; Guy Bertrand
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-15       Impact factor: 15.336

8.  An overview of N-heterocyclic carbenes.

Authors:  Matthew N Hopkinson; Christian Richter; Michael Schedler; Frank Glorius
Journal:  Nature       Date:  2014-06-26       Impact factor: 49.962

9.  Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents.

Authors:  Jacob Fernández-Gallardo; Benelita T Elie; Mercedes Sanaú; María Contel
Journal:  Chem Commun (Camb)       Date:  2016-02-21       Impact factor: 6.222

10.  N, N'-Olefin functionalized bis-imidazolium gold(I) salt is an efficient candidate to control keratitis-associated eye infection.

Authors:  Tapastaru Samanta; Gourisankar Roymahapatra; William F Porto; Saikat Seth; Sudipta Ghorai; Suman Saha; Jayangshu Sengupta; Octávio L Franco; Joydev Dinda; Santi M Mandal
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.